Underwriters buy additional $658 mln in Teva Pharm shares

TEL AVIV, Jan 3 (Reuters) - The underwriters for Teva Pharmaceutical Industries' share offering last month have exercised their over-allotment option to purchase additional shares worth $658 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.